How popular isOpenEvidence?
In September 2026, people searched for OpenEvidence by name about 1.8 million times worldwide, a 50% increase from the previous year. These searches made up 51.5% of all global clinical decision support platform searches, placing OpenEvidence first out of eight platforms. When we asked both ChatGPT and Google AI Overviews about clinical decision support platforms, OpenEvidence appeared in two of the five answers and was the fourth most recommended of the eight.
OpenEvidence is the most searched of 8 competitors and the fourth most recommended in AI answers.
OpenEvidenceShare of searches 51.5%Mentioned in 2 of 5 AI answersPlace in AI recommendations 4th
UpToDateShare of searches 28.2%Mentioned in 4 of 5 AI answersPlace in AI recommendations 1st
ElsevierShare of searches 10.4%Mentioned in 1 of 5 AI answersPlace in AI recommendations –
IsabelShare of searches 4.6%Mentioned in 0 of 5 AI answersPlace in AI recommendations –
Wolters KluwerShare of searches 3.8%Mentioned in 3 of 5 AI answersPlace in AI recommendations 6th
Follow OpenEvidence and get free monthly updates on what changed
By continuing you'll get index updates and occasional product news from Brandwave. Unsubscribe any time. Privacy
Top clinical decision support platforms in ChatGPT and Google AI Overviews
In three ChatGPT questions and two Google AI Overviews, OpenEvidence was mentioned in two out of five: in two of the three ChatGPT answers, but not in either of the two Google AI Overviews. OpenEvidence is the fourth most recommended of the eight.
Most recommended by AI
Brands get a higher ranking if they are mentioned earlier in the answers.
UpToDate1st
DynaMed2nd
VisualDx3rd
OpenEvidence4th
BMJ Best Practice5th
Wolters Kluwer6th
Elsevier–
Isabel–
Mentioned by AI
Each dot is one answer, filled in when that answer mentions the brand.
UpToDate4 of 5Named in 3 of 3 ChatGPT answersNamed in 1 of 2 Google answers
Wolters Kluwer3 of 5Named in 2 of 3 ChatGPT answersNamed in 1 of 2 Google answers
DynaMed3 of 5Named in 3 of 3 ChatGPT answersNamed in 0 of 2 Google answers
OpenEvidence2 of 5Named in 2 of 3 ChatGPT answersNamed in 0 of 2 Google answers
VisualDx2 of 5Named in 2 of 3 ChatGPT answersNamed in 0 of 2 Google answers
Elsevier1 of 5Named in 0 of 3 ChatGPT answersNamed in 1 of 2 Google answers
BMJ Best Practice1 of 5Named in 1 of 3 ChatGPT answersNamed in 0 of 2 Google answers
Isabel0 of 5Named in 0 of 3 ChatGPT answersNamed in 0 of 2 Google answers
See every answer about clinical decision support platforms
5 answers
Asked ChatGPT
“Which clinical decision support platform should I use?”
Asked ChatGPT
“What are the best clinical decision support platforms?”
Asked ChatGPT
“What's the best clinical decision support platform for evidence based care?”
Searched Google, AI Overview
“clinical decision support software”
Searched Google, AI Overview
“clinical decision support platforms”
Not named in any answer:
Brands are shown in the order each answer named them. The survey took place in the United States on October 20, 2026.
Which clinical decision support platforms compete with OpenEvidence?
Share of searches by month for OpenEvidence, UpToDate, Elsevier, Isabel, Wolters Kluwer. The figures are in the table below the chart.
View monthly share of searches table
| Month | OpenEvidence | UpToDate | Elsevier | Isabel | Wolters Kluwer | DynaMed | BMJ Best Practice | VisualDx |
|---|---|---|---|---|---|---|---|---|
| Oct 2025 | 38.8% | 38.8% | 11.7% | 4.3% | 4.3% | 1.1% | 0.58% | 0.39% |
| Nov 2025 | 34% | 41.5% | 12.5% | 5.6% | 4.6% | 0.92% | 0.5% | 0.41% |
| Dec 2025 | 37.8% | 37.8% | 11.4% | 6.2% | 5.1% | 0.84% | 0.56% | 0.37% |
| Jan 2026 | 39.1% | 39.1% | 9.6% | 5.3% | 5.3% | 0.87% | 0.47% | 0.32% |
| Feb 2026 | 42% | 34.4% | 10.4% | 4.6% | 6.9% | 0.76% | 0.62% | 0.34% |
| Mar 2026 | 43.3% | 35.3% | 10.6% | 3.9% | 4.8% | 0.78% | 0.96% | 0.35% |
| Apr 2026 | 48.8% | 32.5% | 9.8% | 3.6% | 3.6% | 0.72% | 0.59% | 0.32% |
| May 2026 | 47.6% | 31.7% | 9.6% | 5.2% | 4.3% | 0.7% | 0.57% | 0.31% |
| Jun 2026 | 49.1% | 32.7% | 8% | 4.4% | 4.4% | 0.59% | 0.4% | 0.32% |
| Jul 2026 | 53.5% | 29.3% | 7.2% | 4.8% | 3.9% | 0.53% | 0.35% | 0.35% |
| Aug 2026 | 52.6% | 28.8% | 8.7% | 4.7% | 3.9% | 0.64% | 0.35% | 0.35% |
| Sep 2026 | 51.5% | 28.2% | 10.4% | 4.6% | 3.8% | 0.63% | 0.51% | 0.34% |
| Rank | Brand | Share of searches | Estimated monthly branded searches | vs prior month | Share change |
|---|---|---|---|---|---|
| 1, held 1st | 51.5% | 1.8M | 0% | -1.1 points | |
| 2, held 2nd | 28.2% | 1M | 0% | -0.6 points | |
| 3, held 3rd | 10.4% | 368K | +22.3% | +1.7 points | |
| 4, held 4th | 4.6% | 165K | 0% | -0.1 points | |
| 5, held 5th | 3.8% | 135K | 0% | -0.1 points | |
| 6, held 6th | 0.63% | 22.2K | 0% | 0 points | |
| 7, held 7th | 0.51% | 18.1K | +49.6% | +0.2 points | |
| 8, held 8th | 0.34% | 12.1K | 0% | 0 points |
51.5%
Held 1st. 1.8M estimated branded searches, 0% vs prior month. Share -1.1 points.
2.
UpToDate28.2%
Held 2nd. 1M estimated branded searches, 0% vs prior month. Share -0.6 points.
3.
Elsevier10.4%
Held 3rd. 368K estimated branded searches, +22.3% vs prior month. Share +1.7 points.
4.
Isabel4.6%
Held 4th. 165K estimated branded searches, 0% vs prior month. Share -0.1 points.
3.8%
Held 5th. 135K estimated branded searches, 0% vs prior month. Share -0.1 points.
6.
DynaMed0.63%
Held 6th. 22.2K estimated branded searches, 0% vs prior month. Share 0 points.
0.51%
Held 7th. 18.1K estimated branded searches, +49.6% vs prior month. Share +0.2 points.
8.
VisualDx0.34%
Held 8th. 12.1K estimated branded searches, 0% vs prior month. Share 0 points.
Compare popularity between OpenEvidence and its closest rivals
Every comparison with OpenEvidence
7 comparisons
How has branded search demand for OpenEvidence changed worldwide over the last 12 months?
3 findings
- Across the 12 months ending September 2026, estimated monthly branded searches for OpenEvidence worldwide rose from 1.2M to 1.8M.
- Across the 12 months ending September 2026, OpenEvidence’s share of searches among clinical decision support platforms worldwide increased from 38.8% to 51.5%.
- Across the 12 months ending September 2026, OpenEvidence’s share of searches among clinical decision support platforms worldwide peaked at 53.5% in July 2026 and was lowest at 34% in November 2025.
How did search popularity change for clinical decision support platforms worldwide in September 2026?
6 changes

In September 2026, Elsevier gained share of searches among clinical decision support platforms worldwide, from 8.7% to 10.4%.

In September 2026, OpenEvidence lost share of searches among clinical decision support platforms worldwide, from 52.6% to 51.5%.

In September 2026, UpToDate lost share of searches among clinical decision support platforms worldwide, from 28.8% to 28.2%.

Wolters Kluwer’s share of searches among clinical decision support platforms worldwide has lost ground for 3 months in a row, from 4.4% to 3.8% in September 2026.

Estimated monthly branded searches for Isabel worldwide rose 22.2% over 12 measured months, from 135K to 165K in September 2026.

Estimated monthly branded searches for DynaMed worldwide fell 32.9% over 12 measured months, from 33.1K to 22.2K in September 2026.
How are OpenEvidence’s branded searches counted?
1 search term
Brandwave collects information about searches that people make online using OpenEvidence’s name. When viewed over time, estimated search volumes for this branded term can be used to understand whether interest in the brand is growing, holding steady, or fading.
- openevidence
Do you work for OpenEvidence? To request corrections or removal please contact us via our support page and we will be happy to assist.

Is OpenEvidence your brand?
Put your own campaigns, spend and outcomes next to this demand line, so you can see which of your marketing lined up with the movements above.